How Low Will Invo Bioscience Inc. (OTCMKTS:IVOB) Fall?

Unfortunately for all the people that were hyped up by its latest announcement, Invo Bioscience Inc. (OTCMKTS:IVOB)’s jump didn’t last. It crashed 10.00% on Friday’s session, and if you take a closer look, similarities are to be found between Friday’s chart and the pattern that the ticker is drawing in today’s early trading.

Suffice it to say that if the ticker continues the way it has started, many more investors will be disappointed by the end of today’s trading session. However, it should be said that it was not exactly a secret that this is the most likely course for IVOB. Why?

Because all the company had going for it was one announcement. Sure, it was a big, boastful announcement – but it was clear from the very get-go that even one such as it couldn’t keep the ticker up for very long if there is nothing else known about the company.

And, as far as due diligence is concerned, there really isn’t anything else know about IVOB. Its newsfeed is empty – just as empty as the “filings and disclosure” section of its OTC Markets profile. Oh, there are some reports there… But the most recent one, barring the 8-K announcing the press release we already talked about, is an NT 10-K, which was received on Mar 30, 2012.

With no filings to read, there is no way to know how the company is actually doing, financially. Does it have enough money to capitalize on this awesome opportunity? How much debt has it racked over the years? Does any of it carry toxic convertible provisions that could harm investor value?

There are just too many things that investors don’t know and can’t control, or even predict in this situation, that make committing to IVOB stock nothing less than a blind gamble.

That is why it is important for investors need to see it for what it is and act according to that knowledge.